Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 326 studies with search of: | "Gliosarcoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
|
||||
2 | Recruiting |
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
|
||||
3 | Recruiting |
Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas
|
||||
4 | Active, not recruiting |
Avastin in Combo w Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas
|
||||
5 | Active, not recruiting |
Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients
|
||||
6 | Active, not recruiting |
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors
|
||||
7 | Recruiting |
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
|
||||
8 | Recruiting |
Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
||||
9 | Recruiting |
Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma
|
||||
10 | Active, not recruiting |
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
|
||||
11 | Active, not recruiting |
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
|
||||
12 | Recruiting |
Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
|
||||
13 | Active, not recruiting |
Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
|
||||
14 | Active, not recruiting |
Ph II Imatinib Mesylate + Hydroxyurea in Treatment for Pts w Recurrent/Progressive Meningioma
|
||||
15 | Recruiting |
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
|
||||
16 | Active, not recruiting |
Sarasar and Temodar for Glioblastoma Multiforme Patients
|
||||
17 | Active, not recruiting |
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
|
||||
18 | Recruiting |
Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG
|
||||
19 | Not yet recruiting |
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
|
||||
20 | Recruiting |
Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)
|
Previous Page | Studies Shown (1-20) | Next (21-40) |